Finanzen von Ardent Health Inc (ARDT)ARDTArdent Health Inc

Evaluating the bottom line, Ardent Health Inc maintains a gross margin of 55.77%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.47%, while the net margin is 2.14%. These profitability ratios, combined with a Return on Equity (ROE) of 6.01%, provide a clear picture of how effectively ARDT converts its operational activities into shareholder value.

In the context of the broader market, ARDT competes directly with industry leaders such as SGRY and CYH. With a market capitalization of $1.55B, it holds a significant position in the sector. When comparing efficiency, ARDT's gross margin of 55.77% stands against SGRY's 17.78% and CYH's 81.98%. Such benchmarking helps identify whether Ardent Health Inc is trading at a premium or discount relative to its financial performance.

Ardent Health's total revenue for Q2 2026 was $1.62 billion, a 1.8% decline year-over-year, although it beat market expectations by $30 million. The gross margin remains strong at 55.77%, but net income has fluctuated, with a recent net income of $16.9 million in Q2 2026.